Finance Watch: Ferring Shutters San Diego R&D Site As Even Money-Making Firms Cut Costs
Searches For Strategic Alternatives, Workforce Reductions Ongoing Broadly
Restructuring Edition: After reporting record revenue, but lower profits due to rising costs, Ferring has decided to consolidate R&D in Europe. Also, Codiak has filed for Chapter 11 bankruptcy and will sell off its assets, while Exicure, Applied Molecular Transport, Gamida Cell and others revealed new job cuts.